SARS-CoV-2 Antigen Rapid Qualitative Test Type A

Lp-PLA2 Rapid Quantitative Test(Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the lipoprotein-associated phospholipase A2 (Lp-PLA2) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

The Biotime CCP Rapid Quantitative Test is intended to quantify the concentration of CCP in human serum, plasma and whole blood on Biotime FIA Analyzer by fluorescent immunoassay. The test is used as an aid detection of rheumatoid arthritis. -Fluorescence immunoassay -Rheumatoid arthritis For in vitro diagnostic use only. For professional use only.

TheCMV IgG/IgM Rapid Test is an in vitro immunoassay for the in vitro qualitative determination of IgG and IgM class antibodies toCMV in human serum. IgG results with this assay are used to indicate past or recent infection with CMV. IgM results obtained with this assay are used as an aid in the diagnosis of acute or recent CMV infections. CMV IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Cytomegalovirus (CMV) infection -For in vitro diagnostic use only. For professional use only.

The Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test is intended to qualify the SARS-CoV-2 IgG and IgM antibody in human plasma, serum or whole blood by colloidal gold immunochromatography assay. The test can be used as an aid detection to SARS-CoV-2 infection and thus caused COVID-19 disease.

The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.

Prolactin is the hormone that tells the body to make breast milk when a person is pregnant or breast-feeding. Production of prolactin takes place in the pituitary gland. For those who are not pregnant or breast-feeding, there are only low levels of prolactin in the body.

The BiotimeTSH/FT3/FT4Rapid Quantitative Test is intended to quantitatively detect the concentration of thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), and free thyroxine (FT4) in human serum and plasma samples on the Biotime FIA Analyzer by fluorescent immunoassay. The test is used as an adjunctive diagnosis of thyroid function. For in vitro diagnostic use only. For professional use only.